Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine

Authors :: Lallemant, Marc
Ngo-Giang-Huong, Nicole
Jourdain, Gonzague
Traisaithit, Patrinee
Cressey, Tim R.
Collins, Intira J.
Jarupanich, Tapnarong
Sukhumanant, Thammanoon
Achalapong, Jullapong
Sabsanong, Prapan
Chotivanich, Nantasak
Winiyakul, Narong
Ariyadej, Surabon
Kanjanasing, Annop
Ratanakosol, Janyaporn
Hemvuttiphan, Jittapol
Kengsakul, Karun
Wannapira, Wiroj
Sittipiyasakul, Veerachai
Pornkitprasarn, Witaya
Liampongsabuddhi, Prateung
McIntosh, Kenneth
Van Dyke, Russell B.
Frenkel, Lisa M.
Koetsawang, Suporn
Le Coeur, Sophie
Kanchana, Siripon
Source :: Clinical Infectious Diseases. March 15, 2010, Vol. 50 Issue 6, p898, 9 p.
Publication Year :: 2010

Subjects :: HIV infection -- Drug therapy
HIV infection -- Prevention
HIV infection -- Research
Zidovudine -- Dosage and administration
Zidovudine -- Research
Didanosine -- Dosage and administration
Didanosine -- Research
Nevirapine -- Dosage and administration
Nevirapine -- Research
Drug resistance -- Genetic aspects
Drug resistance -- Research
Gene mutations -- Research
Health
Health care industry

Tools